Selected article for: "drug development and potential candidate serve"
Author: Li, Kunwei; Liang, Yiyu; Cheng, Ao; Wang, Qi; Li, Ying; Wei, Haocheng; Zhou, Changzheng; Wan, Xinhuan
Title: Antiviral Properties of Baicalin: a Concise Review
  • Cord-id: emhvh13d
  • Document date: 2021_10_6
    • ID: emhvh13d
    Snippet: Baicalin is one of the bioactive flavonoid glycosides isolated from the dried root of Scutellaria baicalensis Georgi, Lamiaceae, with antiviral properties. In recent years, the antiviral activity of baicalin has been widely investigated to explore its molecular mechanism of action. In this mini-review, the molecular mechanisms of action of baicalin as an antiviral agent are evaluated, which included three categories: the inhibition or stimulation of JAK/STAT, TLRs, and NF-κB pathways; up or dow
    Document: Baicalin is one of the bioactive flavonoid glycosides isolated from the dried root of Scutellaria baicalensis Georgi, Lamiaceae, with antiviral properties. In recent years, the antiviral activity of baicalin has been widely investigated to explore its molecular mechanism of action. In this mini-review, the molecular mechanisms of action of baicalin as an antiviral agent are evaluated, which included three categories: the inhibition or stimulation of JAK/STAT, TLRs, and NF-κB pathways; up or down modulation of the expression levels of IFN, IL, SOCS1/3, PKR protein, Mx1 protein, and AP-1 protein; and inhibition of cell apoptosis caused by virus infection. In addition, clinical studies of baicalin are also discussed. This literature search suggested that baicalin can serve as a potential candidate for the development of a novel broad-spectrum antiviral drug. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43450-021-00182-1.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and administration route: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • action mechanism and administration route formulation: 1
    • action mechanism and long history: 1, 2, 3, 4, 5
    • action mechanism and low bioavailability: 1, 2
    • action mechanism and lung alveolar: 1, 2, 3
    • action mechanism and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • action mechanism and lung injury index: 1
    • action mechanism and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • action mechanism and lung virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • action mechanism and lung virus titer: 1
    • action mechanism and lymphatic system: 1
    • action mechanism and macrophage secretion: 1
    • activator signal transducer and administration route: 1
    • activator signal transducer and lung alveolar: 1
    • activator signal transducer and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • long history and lung injury: 1, 2
    • long history and lung tissue: 1
    • long history and lung virus: 1
    • long history and lyophilized powder: 1